CFH and autoimmune hepatitis: Therefore, the administration of factor H may be a therapeutic option for patients with uncontrolled AIH associated with low circulating levels of factor H. There were no significant differences between the rate of relapse in patients with AIH treated with prednisolone monotherapy and that of patients treated with prednisolone and azathioprine therapy in this study.